Cost-Effectiveness Analysis of Asciminib in Patients With Chronic Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors in Colombia.

bosutinib - Generic mfg.

Iclusig (ponatinib) - Takeda

Scemblix (asciminib) - Novartis

dasatinib - Generic mfg.

nilotinib - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42720643

Juan Alejandro Ospina; Mateo Ceballos; Natalia Prieto; Paola Jaramillo; Pieralessandro Lasalvia; Sara Arias; Virginia Abello

Sep 11, 2026